VIENNA – The immune checkpoint inhibitor nivolumab extended overall survival by 5.4 months compared with standard therapy in patients with advanced kidney cancer in the phase III CheckMate 025...
SAN FRANCISCO – Many younger women diagnosed with triple-negative breast cancers do not get tested for BRCA, despite guideline recommendations, investigators report.
Among 173 women with...
SAN FRANCISCO – MRI-screening may improve the detection of biologically relevant breast cancer in women who are at average-risk, and reduce the interval-cancer rate down to 0%, at a low...
SAN FRANCISCO – The use of aromatase inhibitors (AIs) in the adjuvant setting appears to delay the development of contralateral breast cancer, and this effect was particularly prevalent among breast...
DENVER – Genomic testing in young patients with lung cancer is critical, as the majority have adenocarcinomas harboring driver alterations that can be targeted with drugs available today, suggested a...
DENVER – Once again, angiogenesis inhibitors have been examined for benefit against advanced non–small cell lung cancer (NSCLC) and have been found wanting.
Results of a meta-analysis limited to...
DENVER – It’s never too late to quit smoking, results of lung cancer screening trials confirm.
Among more than 3,300 heavy smokers over age 50 who took part in two low-dose CT (LDCT) screening...
Forgoing androgen deprivation therapy cuts rather than raises overall and cardiac mortality in certain patients with prostate cancer, depending on their comorbidities, according to a Research Letter...
Recurrence rates of ductal carcinoma in situ (DCIS ) have declined significantly over 3 decades, with the improvements likely because of better screening and pathologic assessment, investigators...
